Impact of cardiovascular risk factors and medication use on the efficacy of remote ischaemic conditioning: Post hoc subgroup analysis of a randomised controlled trial

BMJ Open

Volumn 5, Issue 4, 2015, Pages

  Sloth, Astrid Drivsholm ^a   Schmidt, Michael Rahbek ^a   Munk, Kim ^a   Schmidt, Morten ^a   Pedersen, Lars ^a   Sørensen, Henrik Toft ^a   Bøtker, Hans Erik ^a   Bottcher, M ^b   Kaltoft, A K ^b   Terkelsen, C J ^b   Andersen, N H ^b   Hansen, T M ^b   Trautner, S ^b   Lassen, J F ^b   Christiansen, E H ^b   Krusell, L R ^b   Kristensen, S D ^b   Thuesen, L ^b   Nielsen, S S ^b   Rehling, M ^b   Nielsen, T T ^b   more..

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIMEPIRIDE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN; METFORMIN; NITRIC ACID DERIVATIVE; GLUCOSE BLOOD LEVEL; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE CUFF; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC PRECONDITIONING; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STATISTICAL SIGNIFICANCE; AGED; ARM; BLOOD; BLOOD FLOW; CARDIAC MUSCLE; CARDIOVASCULAR DISEASES; GLUCOSE BLOOD LEVEL; HEART INFARCTION PREVENTION; ISCHEMIA; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MYOCARDIAL INFARCTION; PATHOLOGY; PROCEDURES; RISK FACTOR; SPHYGMOMANOMETER; TREATMENT OUTCOME; VASCULARIZATION;

AGED; ARM; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISCHEMIA; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; REGIONAL BLOOD FLOW; RISK FACTORS; SMOKING; SPHYGMOMANOMETERS; TREATMENT OUTCOME;

EID: 84926456942     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006923     Document Type: Article

References (25)

1. Przyklenk K, Bauer B, Ovize M, et al. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993;87:893-9.
2. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002;106:2881-3.
3. Brevoord D, Kranke P, Kuijpers M, et al. Remote ischemic conditioning to protect against ischemia-reperfusion injury: a systematic review and meta-analysis. PLoS ONE 2012;7:e42179.
4. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013;381:166-75.
5. Ferdinandy P, Hausenloy DJ, Heusch G, et al. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 2014;66:1142-74.
6. McCafferty K, Forbes S, Thiemermann C, et al. The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. Dis Model Mech 2014;7:1321-33.
7. Botker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010;375:727-34.
8. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
9. Grann AF, Erichsen R, Nielsen AG, et al. Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol 2011;3:133-8.
10. Gould W. sg11.1: Quantile regression with bootstrapped standard erros. Stata Technical Bulletin 9 1992:19- 21.
11. Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol 2014;34:509-15.
12. Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res 2009;83:247-61.
13. Moro L, Pedone C, Mondi A, et al. Effect of local and remote ischemic preconditioning on endothelial function in young people and healthy or hypertensive elderly people. Atherosclerosis 2011;219:750-2.
14. Schmidt MR, Stottrup NB, Michelsen MM, et al. Remote ischemic preconditioning impairs ventricular function and increases infarct size after prolonged ischemia in the isolated neonatal rabbit heart. J Thorac Cardiovasc Surg 2014;147:1049-55.
15. D'Ascenzo F, Moretti C, Omede P, et al. Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials. EuroIntervention 2014;9:1463-71.
16. Xu X, Zhou Y, Luo S, et al. Effect of remote ischemic preconditioning in the elderly patients with coronary artery disease with diabetes mellitus undergoing elective drug-eluting stent implantation. Angiology 2014;65:660-6.
17. Jensen RV, Stottrup NB, Kristiansen SB, et al. Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients. Basic Res Cardiol 2012;107:285.
18. Povlsen JA, Lofgren B, Dalgas C, et al. Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation. PLoS ONE 2013;8:e64093.
19. Voucharas C, Lazou A, Triposkiadis F, et al. Remote preconditioning in normal and hypertrophic rat hearts. J Cardiothorac Surg 2011;6:34.
20. Ludman A, Venugopal V, Yellon DM, et al. Statins and cardioprotection - more than just lipid lowering? Pharmacol Ther 2009;122:30-43.
21. Mensah K, Mocanu MM, Yellon DM. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 2005;45:1287-91.
22. Ludman AJ, Hausenloy DJ, Babu G, et al. Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial. Basic Res Cardiol 2011;106:1387-95.
23. Yang JH, Hahn JY, Song YB, et al. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. JACC Cardiovasc Interv 2014;7:592-601.
24. Zhou C, Liu Y, Yao Y, et al. Beta-blockers and volatile anesthetics may attenuate cardioprotection by remote preconditioning in adult cardiac surgery: a meta-analysis of 15 randomized trials. J Cardiothorac Vasc Anesth 2013;27:305-11.
25. Ahnve S, Angelin B, Edhag O, et al. Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention. J Intern Med 1989;226:297-301.